SafeTraces Leads $39 Million ARPA-H BREATHE Program for Indoor Air Quality
SafeTraces has been selected as a Prime Performer for the ARPA-H Building Resilient Environments for Air and Total Health (BREATHE) program, as announced in a press release. The initiative, under a multi-year other transaction agreement (OTA) worth up to $39 million, aims to develop and deploy real-time biosensors, risk assessment software, and automated building controls to improve indoor air quality.
SafeTraces will lead a team comprising Siemens, Ginkgo Bioworks, Gate Scientific, Stanford University School of Medicine, Penn State University, Uniformed Services University, Metis Foundation, and Linda Lee Consulting. The team will support the Defense Health Agency (DHA) within the U.S. Department of War, focusing on enhancing health readiness and biodefense at facilities like Walter Reed Medical Center and Brooke Army Medical Center.
The BREATHE program targets the development of tools to sense airborne bioaerosols, assess indoor air quality exposure risk, and deliver smart building interventions. This effort is crucial as most people spend over 90% of their time indoors, where the risk of airborne infection transmission is higher. SafeTraces' existing platforms, such as the veriDART® and PathogenSentinel™, will be further advanced to meet the program's goals.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Sep 29 Truven launches MarketScan Snapshot for healthcare data checks Sep 29 Omega Healthcare Wins Gold in 2026 AI Breakthrough Awards Sep 29 Phylo Launches Target Atlas for Drug Target Prioritization Sep 29 ChromAgeNet Detects Aging Signs in Blood Stem Cell Images Sep 29 Axxess Partners With Eazewell for Hospice Family SupportLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
LUNGevity Awards $2 Million for Lung Nodule Risk Studies
Atman Health Wins ARPA-H Award to Build Heart Failure AI
ARPA-H Awards UpDoc Up to $9.2 Million for Clinical AI
Rapta Raises $8 Million for Manufacturing Quality Assurance AI
Praeses Secures Air Force Data Fusion Contract With $79 Million Ceiling
Daily AI Brief: the AI news that matters, in your inbox.